黑山共和国 - 克罗地亚文 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

amicus pharma doo podgorica - četvorovalentna vakcina protiv gripa (fragmentisani virus, inaktivisana) - suspenzija za injekciju u napunjenom injekcionom špricu - 15mcg/0.5ml + 15mcg/0.5ml + 15mcg/0.5ml + 15mcg/0.5ml

黑山共和国 - 克罗地亚文 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - vakcina protiv gripa (površinski antigeni, inaktivisana) - suspenzija za injekciju u napunjenom injekcionom špricu - 15mcg/0.5ml + 15mcg/0.5ml + 15mcg/0.5ml

黑山共和国 - 克罗地亚文 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - vakcina protiv gripa (površinski antigeni, inaktivisana) - suspenzija za injekciju u napunjenom injekcionom špricu - 15mcg/0.5ml + 15mcg/0.5ml + 15mcg/0.5ml + 15mcg/0.5ml

黑山共和国 - 克罗地亚文 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - vakcina protiv gripa (površinski antigeni, inaktivisana) - suspenzija za injekciju u napunjenom injekcionom špricu - 15mcg/0.5ml + 15mcg/0.5ml + 15mcg/0.5ml + 15mcg/0.5ml

黑山共和国 - 克罗地亚文 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - vakcina protiv gripa (površinski antigeni, inaktivisana) - suspenzija za injekciju u napunjenom injekcionom špricu - 15mcg/0.5ml + 15mcg/0.5ml + 15mcg/0.5ml

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

astrazeneca ab - a/darwin/9/2021 (h3n2) - like strain (a/norway/16606/2021, medi 355293) / a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/1/2020, medi 340505) / b/austria/1359417/2021 - like strain (b/austria/1359417/2021, medi 355292) / b/phuket/3073/2013 - like strain (b/phuket/3073/2013, medi 306444) - gripa, ljudska - cjepivo protiv gripe, gripa, živa аттенуированная - prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. upotreba fluenz tetra trebala bi se temeljiti na službenim preporukama.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

seqirus netherlands b.v. - a/darwin/6/2021(h3n2)-like strain (a/darwin/11/2021, wild type) / a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) / b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021) / b/phuket/3073/2013-like virus (b/singapore/inftt-16-0610/2016, wild type) - gripa, ljudska - virus gripe, инактивированная, split ili površinski antigen - prophylaxis of influenza in adults and children from 2 years of age. flucelvax tetra treba primjenjivati u skladu sa službenim preporukama.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

roche registration gmbh - baloxavir marboxil - gripa, ljudska - antivirusni lijekovi za sustavnu uporabu - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

seqirus s.r.l.  - antigeni površinskih virusa influence, inaktivirani: a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cjepiva protiv gripe - profilakcija gripe u službeno prijavljenoj pandemijskoj situaciji. cjepivo protiv influence pandemije treba koristiti u skladu s službenim smjernicama.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - gripa, ljudska - cjepiva - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.